423 related articles for article (PubMed ID: 8661814)
21. Contemporary surgical management of the Zollinger-Ellison syndrome in multiple endocrine neoplasia type 1.
Albers MB; Manoharan J; Bartsch DK
Best Pract Res Clin Endocrinol Metab; 2019 Oct; 33(5):101318. PubMed ID: 31521501
[TBL] [Abstract][Full Text] [Related]
22. Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome.
Pipeleers-Marichal M; Somers G; Willems G; Foulis A; Imrie C; Bishop AE; Polak JM; Häcki WH; Stamm B; Heitz PU
N Engl J Med; 1990 Mar; 322(11):723-7. PubMed ID: 1968616
[TBL] [Abstract][Full Text] [Related]
23. Long-term results of a selective surgical approach to management of Zollinger-Ellison syndrome in patients with MEN-1.
Mortellaro VE; Hochwald SN; McGuigan JE; Copeland EM; Vogel SB; Grobmyer SR
Am Surg; 2009 Aug; 75(8):730-3. PubMed ID: 19725300
[TBL] [Abstract][Full Text] [Related]
24. Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic-duodenal disease. Results in the treatment of 40 patients with Zollinger-Ellison syndrome, hypoglycaemia or both.
Thompson NW
J Intern Med; 1998 Jun; 243(6):495-500. PubMed ID: 9681848
[TBL] [Abstract][Full Text] [Related]
25. Duodenal gastrinomas, duodenotomy, and duodenal exploration in the surgical management of Zollinger-Ellison syndrome.
Thompson NW; Pasieka J; Fukuuchi A
World J Surg; 1993; 17(4):455-62. PubMed ID: 8103249
[TBL] [Abstract][Full Text] [Related]
26. [Carcinoid tumors and neuroendocrine carcinomas of the stomach. Prognosis and therapeutic management. Study of 6 cases].
Moreaux J; Martin E; Saliou C
Ann Chir; 1997; 51(2):121-9. PubMed ID: 9297867
[TBL] [Abstract][Full Text] [Related]
27. Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type I multiple endocrine neoplasia.
Ruszniewski P; Podevin P; Cadiot G; Marmuse JP; Mignon M; Vissuzaine C; Bonfils S; Lehy T
Pancreas; 1993 May; 8(3):295-304. PubMed ID: 8097874
[TBL] [Abstract][Full Text] [Related]
28. Biochemically curative surgery for gastrinoma in multiple endocrine neoplasia type 1 patients.
Imamura M; Komoto I; Ota S; Hiratsuka T; Kosugi S; Doi R; Awane M; Inoue N
World J Gastroenterol; 2011 Mar; 17(10):1343-53. PubMed ID: 21455335
[TBL] [Abstract][Full Text] [Related]
29. [Recent trend of diagnosis and treatment for Zollinger-Ellison syndrome].
Imamura M; Komoto I; Doi R
Gan To Kagaku Ryoho; 2005 Feb; 32(2):147-51. PubMed ID: 15751623
[TBL] [Abstract][Full Text] [Related]
30. A personal experience with pancreatic and duodenal neuroendocrine tumors.
Jordan PH
J Am Coll Surg; 1999 Nov; 189(5):470-82. PubMed ID: 10549736
[TBL] [Abstract][Full Text] [Related]
31. Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome.
Alexander HR; Fraker DL; Norton JA; Bartlett DL; Tio L; Benjamin SB; Doppman JL; Goebel SU; Serrano J; Gibril F; Jensen RT
Ann Surg; 1998 Aug; 228(2):228-38. PubMed ID: 9712569
[TBL] [Abstract][Full Text] [Related]
32. [Posterior resection of of the head of the pancreas in malignant duodenal gastrinoma].
Schmidt J; Boedeker H; Zirngibl H
Chirurg; 1997 Apr; 68(4):425-8. PubMed ID: 9206639
[TBL] [Abstract][Full Text] [Related]
33. Recent advances in the localization and surgical management of duodenal gastrinomas.
Lawton GP; Modlin IM
Curr Opin Gen Surg; 1994; ():131-7. PubMed ID: 7583948
[TBL] [Abstract][Full Text] [Related]
34. Case report: optimal tumor cytoreduction and octreotide with durable disease control in a patient with MEN-1 and Zollinger-Ellison syndrome-over a decade of follow-up.
Daniels LM; Khalili M; Morano WF; Simoncini M; Mapow BC; Leaf A; Bowne WB
World J Surg Oncol; 2019 Dec; 17(1):213. PubMed ID: 31818296
[TBL] [Abstract][Full Text] [Related]
35. Biology and management of gastric carcinoid tumours: a review.
Modlin IM; Kidd M; Lye KD
Eur J Surg; 2002; 168(12):669-83. PubMed ID: 15362575
[TBL] [Abstract][Full Text] [Related]
36. A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors.
Berna MJ; Annibale B; Marignani M; Luong TV; Corleto V; Pace A; Ito T; Liewehr D; Venzon DJ; Delle Fave G; Bordi C; Jensen RT
J Clin Endocrinol Metab; 2008 May; 93(5):1582-91. PubMed ID: 18270260
[TBL] [Abstract][Full Text] [Related]
37. [Zollinger-Ellison syndrome].
Fendrich V; Bartsch DK; Langer P; Zielke A; Rothmund M
Chirurg; 2005 Mar; 76(3):217-26. PubMed ID: 15688179
[TBL] [Abstract][Full Text] [Related]
38. [Neuroendocrine tumors of the stomach. Surgery therapy and prognosis].
Bektas H; Länger F; Piso P; Werner U; Musholt TJ; Lehner F; Becker T; Klempnauer J
Chirurg; 2002 Apr; 73(4):331-5. PubMed ID: 12063917
[TBL] [Abstract][Full Text] [Related]
39. The antral mucosa as a new site for endocrine tumors in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndromes.
Bordi C; Corleto VD; Azzoni C; Pizzi S; Ferraro G; Gibril F; Delle Fave G; Jensen RT
J Clin Endocrinol Metab; 2001 May; 86(5):2236-42. PubMed ID: 11344233
[TBL] [Abstract][Full Text] [Related]
40. Gastrinoma: advances in localization and treatment.
Norton JA
Surg Oncol Clin N Am; 1998 Oct; 7(4):845-61. PubMed ID: 9735137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
